Please login to the form below

Not currently logged in

Novo Nordisk settles US insulin pricing dispute for $100m

Novo Nordisk admits no liability or wrongdoing but will pay investors $100m to “avoid the burden, inherent risk and expense of further litigation”

Mysterious big pharma company eyes US biotech Acceleron

AcceleronSpeculation is running high that a major pharma company will make a move on Massachusetts-based pulmonary and haematology biotech Acceleron this week

Lynparza significantly delays disease progression as first-line treatment in prostate cancer

LynparzaNew data show AstraZeneca and Merck‘s PARP inhibitor, Lynparza, delayed disease progression as a first-line treatment in advanced prostate cancer

Rocky start for Biogen’s Alzheimer’s drug Aduhelm

Biogen Idec buildingControversial Alzheimer’s treatment Aduhelm is struggling to realise its potential, with only 100 patients receiving the therapy so far in the US

COVID-19 Pfizer/BioNTech booster approved by FDA and CDC

FDA newThe plan to offer Americans a third, booster shot of the Pfizer/BioNTech COVID-19 vaccine has finally been waved through by the FDA and CDC

AstraZeneca invests in RNA tech platform

AZ NEWAstraZeneca will support research using VaxEquity’s RNA platform then pay at least $195m for each candidate that enters its pipeline

Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%

GileadNew data showing Gilead’s Veklury cuts the risk of hospitalisation for COVID-19 contradicts results of the World Health Organization’s Solidarity study

Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars

Amgen flagCompetition created by biosimilars has delivered $9.8bn in savings over five years and could reduce patients’ out-of-pocket costs by $238m

FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer

FDA newThe drug has been granted accelerated approval, and the companies have also released positive data on first-line treatment

Behaviour change theoryBehaviour change theory

Behaviour change through teamwork – collaborating with stakeholders from across the health ecosystem. Chris Ross examines pharma’s adoption of behaviour change theories and finds an industry in need of a

Latest appointments

COVID-19 Updates and Daily News

Featured jobs


Add my company

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Understanding behaviour change: A Porterhouse Insights specialism
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...